Cascades Reports Results for the Fourth Quarter and Full Year 2022

Cascades Inc. (TSX: CAS) reports its unaudited financial results for the three-month period and fiscal year ended December 31, 2022.

Q4 2022 Highlights
Sales of $1,135 million (compared with $1,174 million in Q3 2022 and $1,028 million in Q4 2021)
As reported
*Operating loss of $(20) million (compared with $25 million in Q3 2022 and $(90) million in Q4 2021)
*Net loss per common share of $(0.27) (compared with a net loss per common share of ($0.02) in Q3 2022 and net earnings per common share of $1.04 in Q4 2021)
*Adjusted (excluding specific items1)
*Earnings before interest, taxes, depreciation and amortization (EBITDA (A)) of $116 million (compared with $111 million in Q3 2022 and $62 million in Q4 2021)
*Net earnings per common share of $0.22 (compared with net earnings per common share of $0.20 in Q3 2022 and a net loss per common share of ($0.09) in Q4 2021)

2022 Annual Highlights
Sales of $4,466 million (compared with $3,956 million in 2021)
As reported
*Operating income of $33 million (compared with $50 million in 2021)
*Net loss per common share of $(0.34) (compared with net earnings per common share of $1.60 in 2021)
Adjusted (excluding specific items1)
*Earnings before interest, taxes, depreciation and amortization (EBITDA (A)) of $376 million (compared with $389 million in 2021)
*Net earnings per common share of $0.37 (compared with net earnings per common share of $0.26 in 2021)
*Net debt1 of $1,966 million as of December 31, 2022 (compared with $2,011 million as of September 30, 2022). Net debt to adjusted EBITDA (A) ratio1 of 5.2x, down from 6.2x as of September 30, 2022.
*Total capital expenditures, net of disposals, of $149 million in Q4 2022 and $482 million in 2022. Forecasted 2023 net capital expenditures of approximately $325 million, including $175 million for the Bear Island containerboard conversion project in Virginia, USA.

Mario Plourde, President and CEO, commented: “We are pleased with our fourth quarter consolidated performance, which showed continued positive momentum in our Tissue Papers segment, and good underlying performance in our packaging segments. The wide-ranging profitability and operational initiatives that we have been progressively implementing throughout our operations gained traction as the year progressed, and fuelled the 10.2% consolidated EBITDA (A) margins in Q4. Our operations have faced more than $475 million of production, raw material, freight and energy cost headwinds within the span of the calendar year 2022 alone, and our teams have done an excellent job at executing multiple countermeasures. These have taken longer in our Tissue Papers segment, where price rebalancing takes time to be realized, but we are encouraged by the progress being made and expect continued benefits to be generated from operational and profitability initiatives across our operations.
details at: https://www.newswire.ca/news-releases/cascades-reports-results-for-the-fourth-quarter-and-full-year-2022-876983961.html

Related Posts

Clearwater Paper Reports Fourth Quarter and Year End 2021 Results

2021 FOURTH QUARTER HIGHLIGHTS *Delivered solid performance due to continued strength in the paperboard business *Managed through increased COVID related absences, supply chain disruptions and weather impacts *Achieved net income of $10 million, or $0.56 per diluted share and Adjusted EBITDA of $56 million *Net sales of $490 million, up 8% compared to the fourth quarter of 2020 *Net debt reduction of $37 million. 2021 FULL YEAR HIGHLIGHTS *Delivered strong performance due to robust demand for paperboard products and solid operational execution *Net loss of $28 million, which includes an after-tax loss of $38 million associated with the closure of Neenah, Wisconsin tissue facility *Net sales of $1.8 billion *Net debt reduction of $69 million

Sonoco ThermoSafe and ACL Airshop Announce Agreement for Handling and Repair of Pegasus ULD Temperature Controlled Bulk Shippers

Sonoco ThermoSafe and ACL Airshop announced a global agreement for the handling and repair of Sonoco ThermoSafe’s Pegasus ULD bulk temperature controlled containers. The Pegasus ULD™ is the world’s first passive bulk temperature controlled container for pharmaceutical use that is an approved unit load device, which allows it to speed through existing international ground handling and customs processes at the lowest possible cost. Engineered with composite materials, the unit load device will offer a lighter solution that is substantially more damage-resistant than traditional metal containers. Additionally, the Pegasus contains a fully integrated, FAA (Federal Aviation Administration) approved telemetry system, providing real-time, cloud-based data on payload and ambient temperature and key environmental factors, precisely synchronized with GPS location. ACL Airshop, headquartered in Greenville, S.C., and with air cargo support capabilities at more than 50 of the world’s top 100 cargo airports, will initially provide pre-conditioning, handling and repair services at air cargo facilities around the world representing key pharma hubs for import and export. As demand for the Pegasus ULD fleet continues to grow, ACL’s global footprint offers Sonoco ThermoSafe the opportunity to rapidly expand.

Elopak selects Little Rock, Arkansas for its new production plant in the USA

Elopak has announced plans to build its first U.S. production plant with the latest state-of-the-art technology for better and more efficient production. The plant will produce Pure-Pak® cartons for liquid dairy, juices, plant-based products and liquid eggs. The new production facility will be located in Little Rock, Arkansas and is expected to start production in H1, 2025. It represents a significant investment for the region of around USD 70 million including the land, the building and the equipment. The new plant will create more than 100 permanent jobs in the region for engineers, printers, operators, logistics specialists and other support groups.
Back To Top
×Close search
Search